Soleno Therapeutics Inc (SLNO) valuation · rev $190.4M
Soleno Therapeutics Inc (SLNO) rev $190.4M.
| Metric | Value |
|---|---|
| Market cap | $2.76B |
| Revenue | $190.4M |
| P/S | 14.5 |
| P/B | 5.6 |
SLNO valuation FAQ
What is SLNO's market cap?
Soleno Therapeutics Inc (SLNO) market cap is $2.76B on the latest cached fundamentals snapshot.
What is SLNO's latest revenue?
Latest cached Soleno Therapeutics Inc (SLNO) revenue was $190.4M. Statements: https://lician.com/financials/slno
What is SLNO's price-to-sales ratio?
Soleno Therapeutics Inc (SLNO) price-to-sales (P/S) is 14.5, cached market cap $2.76B divided by revenue $190.4M.
What is SLNO's price-to-book ratio?
Soleno Therapeutics Inc (SLNO) price-to-book (P/B) is 5.6 on the latest cached fundamentals snapshot.
How many SLNO valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Soleno Therapeutics Inc (SLNO): Market cap, Revenue, P/S, and P/B.
Where is SLNO valuation listed?
Cached valuation multiples for Soleno Therapeutics Inc (SLNO) are listed at https://lician.com/valuation/slno.
Not investment advice. Cached rows, not a live tape.